...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo(3,4-c)carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.
【24h】

Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo(3,4-c)carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.

机译:N-6取代的9-羟基-4-苯基吡咯并(3,4-c)咔唑-1,3(2H,6H)-二酮作为Wee1和Chk1检查点激酶的抑制剂的合成与构效关系。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of N-6 substituted 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones were prepared from N-substituted (5-methoxyphenyl)ethenylindoles. The target compounds were tested for their ability to inhibit the G2/M cell cycle checkpoint kinases, Wee1 and Chk1. Analogues with neutral or cationic N-6 side chains were potent dual inhibitors. Acidic side chains provided potent (average IC(50) 0.057 microM) and selective (average ratio 223-fold) Wee1 inhibition. Co-crystal structures of inhibitors bound to Wee1 show that the pyrrolo[3,4-c]carbazole scaffold binds in the ATP-binding site, with N-6 substituents involved in H-bonding to conserved water molecules. HT-29 cells treated with doxorubicin and then target compounds demonstrate an active Cdc2/cyclin B complex, inhibition of the doxorubicin-induced phosphorylation of tyrosine 15 of Cdc2 and abrogation of the G2 checkpoint.
机译:由N-取代的(5-甲氧基苯基)乙烯基吲哚制备一系列N-6取代的9-羟基-4-苯基吡咯并[3,4-c]咔唑-1,3(2H,6H)-二酮。测试了目标化合物抑制G2 / M细胞周期检查点激酶Wee1和Chk1的能力。具有中性或阳离子N-6侧链的类似物是有效的双重抑制剂。酸性侧链提供有效的(平均IC(50)0.057 microM)和选择性(平均比率223倍)Wee1抑制。与Wee1结合的抑制剂的共晶体结构表明,吡咯并[3,4-c]咔唑支架在ATP结合位点结合,其中N-6个取代基参与H键与保守水分子的结合。用阿霉素然后再用目标化合物处理的HT-29细胞表现出活性的Cdc2 / cyclin B复合物,抑制了阿霉素诱导的Cdc2酪氨酸15的磷酸化并废除了G2检查点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号